← Evidence map

ArticleClinical journal of gastroenterology2020

Real-word efficacy of sofosbuvir, velpatasvir plus ribavirin therapy for chronic hepatitis patients who failed to prior DAA therapy with NS5A-P32 deletion mutated HCV infection.

Shintaro Takaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32656649